Services available for Biocompatibility
Medical Device Biocompatibility Testing
We offer a comprehensive range of biocompatibility tests to evaluate potential biological risks arising from your medical device.
- 4-5 week typical lead time
- Biological Evaluation Plan & Report
- In Vitro & In Vivo methods
- Extractables & Leachables (E&L) Studies
- Also testing following reprocessing procedures or accelerated aging to meet lifecycle requirements
Medical Device Biological Evaluation Plan
We support the safety and regulatory compliance of your medical device through robust Biological Evaluation Plans aligned with ISO 10993‑1, addressing potential biological hazards and risks throughout clinical use.
- 4-6 week typical lead time
- ISO 10993-1 – Biological evaluation of medical devices
- Tailored to meet the requirements of international regulatory bodies
- Provides comprehensive ISO10993 testing plan
- Completed by in-house biocompatibility specialist
Medical Device Biological Evaluation Report
We produce a report which is a collective summary of all data used to assess the biocompatibility of your medical device.
- 2-3 week typical lead time
- ISO 10993-1 – Biological evaluation of medical devices
- Meets the requirements of FDA / MDR
- Provides comprehensive ISO10993 report
- Completed by in-house toxicologist (competent person)
ISO 10993-5 Cytotoxicity Testing
We offer ISO 10993-5 cytotoxicity in vitro tests which evaluate biological risks within the chemical make-up of a medical device.
- 2-4 week typical lead time
- Good Laboratory Practice GLP study
- Biological Evaluation Plan
- Biological Evaluation Report
- ISO 10993-5 – cytotoxicity – in vitro methods
ISO 10993-23 Test for Irritation
We offer ISO 10993-23 tests to determine irritation potential of their devices without the need for animal testing.
- 2-4 week typical lead time
- Good Laboratory Practice GLP study
- Biological Evaluation Plan
- Biological Evaluation Report
- ISO 10993-23 – test for irritation – in vitro methods
Extractables & Leachables (E&L) Testing
We offer comprehensive Extractables & Leachables (E&L) testing to identify and quantify substances, supporting your product’s biocompatibility and regulatory compliance.
- 10-16 weeks typical lead time
- ISO 10993-18
- USP<1663>/<1664>, USP <665>/<1665>
- Aligned with MDR and FDA guidance
- Custom Extractables Study Design
Residual Hydrogen Peroxide Determination
We assess hydrogen peroxide residues remaining on medical devices following H2O2 sterilisation processes to assess biocompatibility and patient safety.
- 2-3 week typical lead time
- BS EN ISO 22441:2022
- BS EN ISO 109931-1:2020
- BS EN ISO 10993-17:2023
- BS EN ISO 10993-18:2020+A1:2023
Clinical Evidence Strategy
We develop a plan to gather the clinical data required to achieve your commercial goals.
- 8-12 week typical lead time
- Pre-market clinical investigation planning to support CE mark and FDA requirements
- Post-market evidence planning for PMCF requirements (EU MDR and FDA)
- Real world evidence planning